Similar articles

• Gene expression changes induced by HIPEC in a murine model of gastric cancer.

  Graziosi L, Mencarelli A, Renga B, Santorelli C, Cantarella F, Bugiantella W, Cavazzoni E, Donini A, Fiorucci S. Graziosi L, et al. In Vivo. 2012 Jan-Feb;26(1):39-45. In Vivo. 2012. PMID: 22210714
• [Continuous hyperthermic peritoneal perfusion (CHPP) therapy in advanced gastric cancer].

  Suzuki H, Miyagishima K, Gasa F, Hakamada K, Seino K, Hada R, Mikami Y, Sugiyama Y, Konn M, Ono K. Suzuki H, et al. Gan To Kagaku Ryoho. 1991 Aug;18(11):1769-72. Gan To Kagaku Ryoho. 1991. PMID: 1908652 Japanese.
• [Efficacy of intraoperative hypotonic peritoneal chemo-hyperthermia combined with early postoperative intraperitoneal chemotherapy on gastric cancer].

  Wei G, Fang GE, Bi JW, Shen XJ, Nie MM, Xue XC, Hua JD. Wei G, et al. Ai Zheng. 2005 Apr;24(4):478-82. Ai Zheng. 2005. PMID: 15820074 Clinical Trial. Chinese.
• [Anaesthesia and intensive care during intraoperative intraperitoneal hyperthermic chemotherapy in patients with gastric cancer (literature review and own clinical experience)].

  Khoronenko VE, Shemetova MM, Drozhzhina OV, Khomyakov VM, Sobolev DD. Khoronenko VE, et al. Anesteziol Reanimatol. 2015 Jan-Feb;60(1):50-4. Anesteziol Reanimatol. 2015. PMID: 26027226 Review. Russian.
• Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.

  Detroz B, Laurent S, Honoré P, Blaffart F, Limet R, Meurisse M. Detroz B, et al. Acta Chir Belg. 2004 Aug;104(4):377-83. Acta Chir Belg. 2004. PMID: 15469146 Review.